ABAudrey Boutonnet

Audrey Boutonnet

*This is an algorithmically generated author record based on publicly available information.

Audrey Boutonnet has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Alisa Burova

    Université de Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM UMR1266, « Genetic vulnerability to addictive and psychiatric disorders » team, Paris, France

    1 shared publication
  • Camille Verebi

    Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Equipe Gorwood/Ramoz Paris France

    1 shared publication
  • Juliette Nectoux

    Service de Médecine Génomique des maladies de système et d'organe, Hôpital Cochin, Assistance Publique. Centre Université de Paris Cité, Paris, France

    1 shared publication
  • Nicolas Lebrun

    Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team “Vulnerability to Psychiatric and Addictive Disorders”, Paris, France

    1 shared publication
  • Nicolas Ramoz

    Universite Paris Cite

    1 shared publication
  • Philibert Duriez

    Université de Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM UMR1266, « Genetic vulnerability to addictive and psychiatric disorders » team, Paris, France

    1 shared publication

Latest Publications

  • Open Access

    Fragmentomics features of cell free DNA in eating disorders

    by Alisa Burova, Camille Verebi, Nicolas Lebrun, Juliette Nectoux, Audrey Boutonnet, Philibert Duriez, Philip Gorwood, Nicolas Ramoz, Thierry Bienvenu

    Eating disorders are lacking reliable biomarkers despite their severe psychiatric and medical burden. In this study, we examined plasma cell-free DNA (cfDNA) from patients with the restrictive (ANR), or binge-purge (ANBP) subtypes of anorexia nervosa, as well as from those with bulimia nervosa (BN), and controls, using the BIABooster electrophoresis method and shallow whole-genome sequencing to characterize cfDNA fragmentomics. While absolute cfDNA concentrations did not differ between groups, patients exhibited consistent qualitative alterations. Patients with BN showed increased cfDNA at the first nucleosomal peak, while all patient groups displayed shifts towards shorter fragments in the second and third nucleosomal peaks. End-motif analysis revealed higher motif diversity and trinucleotide sequence motifs TNN-type enrichment in ANR, together with a lower ratio of trinucleotide sequence motifs CGN to NCG, which has been correlated with hypomethylation. Multivariate analyses demonstrated that ANBP exhibits a distinct molecular profile that is not explained by combined effects of anorexia and bulimia. These findings suggest that cfDNA in eating disorders carries biologically meaningful signatures related to chromatin organization, nuclease activity, and methylation. This supports the potential of cfDNA as a minimally invasive biomarker for the clinical management of eating disorders.